Melatonin prevents X-ray irradiation induced oxidative damagein peripheral blood and spleen of the seasonally breeding rodent, Funambulus pennanti during reproductively active phase
Abstract
Purpose: Biological effects of X-ray irradiation and protection by melatonin on the immune status of a tropical rodent, Funambulus pennanti, was examined by estimating oxidative damage of peripheral blood and spleen and protection by melatonin treatment.
Material and methods: Seventy squirrels were divided into 4 sets of 25, 25, 10 and 10 having subdivisions into a total of eight groups. Squirrels of set 1 (groups A and B) received only normal saline, set 2 (groups C and D) received 25 microg/100 g body weight (bwt) melatonin and set 3 (groups E and F) received 25 microg/100 g bwt vitamin E for four weeks. Groups G and H of set 4 received high doses of melatonin (0.5 mg/100 g bwt) 30 min prior to and 30 min after X-ray irradiation, respectively, and were sacrificed 1 h after irradiation. Groups B and D were sacrificed after 4 h, 24 h, 48 h and 72 h of irradiation for total leukocyte count (TLC) in peripheral blood, percent apoptotic cells and lipid peroxidation (LPO) in spleen while group F was sacrificed after 4 h of irradiation to measure LPO.
Results: Pre-melatonin treatment (25 microg/100 g bwt) restored TLC, percent apoptotic cells and LPO levels of X-ray exposed squirrels. High dose pre-melatonin treatment (0.5 mg/100 g bwt) restored the above conditions significantly while post treatment did not. Vitamin E reduced elevated LPO level in irradiated tissue, but the effect of melatonin was more potent.
Conclusion: Melatonin administration prior to X-ray irradiation prevented radiation-induced oxidative damage during the reproductively active phase of the seasonally breeding rodent suggesting a high protective role of melatonin following X-ray irradiation.
See also:
- Official Web Site: The Di Bella Method;
- Melatonin use in cancer patients have started in 1974, when melatonin prepared according to Prof. Di Bella’s formulation [...]. For 11 days was administered to the patient, admitted to the general medical ward at the Maggiore-Pizzardi Hospital in Bologna, very slowly (over approx. 8 hours) and intravenously administered 1000 mg of melatonin for 11 days. During the course of each day, the patient was intravenously administered 4 saline drips of 500 ml, each containing ten 25 mg bottles of freeze-dried melatonin, lasting 2 hours, totaling 1000 mg per day. No other drug of any kind was administered in order to ascertain the effect of the MLT without interference [...]. From Melatonin with adenosine solubilized in water and stabilized with glycine for oncological treatment - technical preparation, effectivity and clinical findings;
- About Melatonin - In vitro, review and in vivo publications;
- Publication: Melatonin anticancer effects: Review (from Di Bella's Foundation);
- Publication: Key aspects of melatonin physiology: 30 years of research (from Di Bella's Foundation);
- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;
- The Di Bella Method (A Fixed Part - Vitamin C/Ascorbic Acid, 2–4 grams, twice a day orally);
- Beta-Carotene or β-carotene in Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy;
- The Di Bella Method (A Fixed Part - Calcium, 2 grams per day, orally);
- The Di Bella Method (A Fixed Part - Bromocriptine and/or Cabergoline);
- Somatostatin in oncology, the overlooked evidences - In vitro, review and in vivo publications;
- Publication, 2018 Jul: Over-Expression of GH/GHR in Breast Cancer and Oncosuppressor Role of Somatostatin as a Physiological Inhibitor (from Di Bella's Foundation);
- Publication, 2019 Aug: The Entrapment of Somatostatin in a Lipid Formulation: Retarded Release and Free Radical Reactivity (from Di Bella's Foundation);
- Publication, 2019 Sep: Effects of Somatostatin and Vitamin C on the Fatty Acid Profile of Breast Cancer Cell Membranes (from Di Bella's Foundation);
- Publication, 2019 Sep: Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes (from Di Bella's Foundation);
- Publication, 2020 Sep: Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives (from Di Bella's Foundation);
- Oesophageal squamocellular carcinoma: a complete and objective response;
- Pancreatic Adenocarcinoma: clinical records on 17 patients treated with Di Bella's Method;
- Complete objective response to biological therapy of plurifocal breast carcinoma;
- Pleural Mesothelioma: clinical records on 11 patients treated with Di Bella's Method;
- Malignant pleural mesothelioma, stage T3-T4. Consideration of a case study;
- Neuroblastoma: Complete objective response to biological treatment;
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report;






